- Conditions
- SLC13A5 Citrate Transporter Disorder
- Interventions
- TSHA-105
- Drug
- Lead sponsor
- TESS Research Foundation
- Other
- Eligibility
- 2 Years to 20 Years
- Enrollment
- 8 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2031
- U.S. locations
- 1
- States / cities
- Dallas, Texas
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–2
of 2
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Citrate Transporter Deficiency, SLC13A5 Gene Mutation
- Interventions
- triheptanoin
- Drug
- Lead sponsor
- Irina A Anselm
- Other
- Eligibility
- 4 Years to 9 Years
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts